606 related articles for article (PubMed ID: 26214266)
1. Mepolizumab versus placebo for asthma.
Powell C; Milan SJ; Dwan K; Bax L; Walters N
Cochrane Database Syst Rev; 2015 Jul; (7):CD010834. PubMed ID: 26214266
[TBL] [Abstract][Full Text] [Related]
2. Anti-IL5 therapies for asthma.
Farne HA; Wilson A; Powell C; Bax L; Milan SJ
Cochrane Database Syst Rev; 2017 Sep; 9(9):CD010834. PubMed ID: 28933516
[TBL] [Abstract][Full Text] [Related]
3. Anti-IL-5 therapies for asthma.
Farne HA; Wilson A; Milan S; Banchoff E; Yang F; Powell CV
Cochrane Database Syst Rev; 2022 Jul; 7(7):CD010834. PubMed ID: 35838542
[TBL] [Abstract][Full Text] [Related]
4. Anti-IL-5 therapies for chronic obstructive pulmonary disease.
Donovan T; Milan SJ; Wang R; Banchoff E; Bradley P; Crossingham I
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013432. PubMed ID: 33295032
[TBL] [Abstract][Full Text] [Related]
5. Omalizumab for asthma in adults and children.
Normansell R; Walker S; Milan SJ; Walters EH; Nair P
Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD003559. PubMed ID: 24414989
[TBL] [Abstract][Full Text] [Related]
6. Vilanterol and fluticasone furoate for asthma.
Dwan K; Milan SJ; Bax L; Walters N; Powell C
Cochrane Database Syst Rev; 2016 Sep; 9(9):CD010758. PubMed ID: 27582089
[TBL] [Abstract][Full Text] [Related]
7. Sublingual immunotherapy for asthma.
Fortescue R; Kew KM; Leung MST
Cochrane Database Syst Rev; 2020 Sep; 9(9):CD011293. PubMed ID: 32926419
[TBL] [Abstract][Full Text] [Related]
8. Macrolides versus placebo for chronic asthma.
Undela K; Goldsmith L; Kew KM; Ferrara G
Cochrane Database Syst Rev; 2021 Nov; 11(11):CD002997. PubMed ID: 34807989
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of mepolizumab add-on therapy on health-related quality of life and markers of asthma control in severe eosinophilic asthma (MUSCA): a randomised, double-blind, placebo-controlled, parallel-group, multicentre, phase 3b trial.
Chupp GL; Bradford ES; Albers FC; Bratton DJ; Wang-Jairaj J; Nelsen LM; Trevor JL; Magnan A; Ten Brinke A
Lancet Respir Med; 2017 May; 5(5):390-400. PubMed ID: 28395936
[TBL] [Abstract][Full Text] [Related]
10. Inhaled corticosteroids in children with persistent asthma: effects on growth.
Zhang L; Prietsch SO; Ducharme FM
Evid Based Child Health; 2014 Dec; 9(4):829-930. PubMed ID: 25504972
[TBL] [Abstract][Full Text] [Related]
11. Long-acting beta2-agonist in addition to tiotropium versus either tiotropium or long-acting beta2-agonist alone for chronic obstructive pulmonary disease.
Farne HA; Cates CJ
Cochrane Database Syst Rev; 2015 Oct; (10):CD008989. PubMed ID: 26490945
[TBL] [Abstract][Full Text] [Related]
12. Mepolizumab treatment in patients with severe eosinophilic asthma.
Ortega HG; Liu MC; Pavord ID; Brusselle GG; FitzGerald JM; Chetta A; Humbert M; Katz LE; Keene ON; Yancey SW; Chanez P;
N Engl J Med; 2014 Sep; 371(13):1198-207. PubMed ID: 25199059
[TBL] [Abstract][Full Text] [Related]
13. Sublingual immunotherapy for asthma.
Normansell R; Kew KM; Bridgman AL
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD011293. PubMed ID: 26315994
[TBL] [Abstract][Full Text] [Related]
14. Personalised asthma action plans for adults with asthma.
Gatheral TL; Rushton A; Evans DJ; Mulvaney CA; Halcovitch NR; Whiteley G; Eccles FJ; Spencer S
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD011859. PubMed ID: 28394084
[TBL] [Abstract][Full Text] [Related]
15. Vitamin C for asthma and exercise-induced bronchoconstriction.
Milan SJ; Hart A; Wilkinson M
Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD010391. PubMed ID: 24154977
[TBL] [Abstract][Full Text] [Related]
16. Tiotropium versus placebo for chronic obstructive pulmonary disease.
Karner C; Chong J; Poole P
Cochrane Database Syst Rev; 2012 Jul; (7):CD009285. PubMed ID: 22786525
[TBL] [Abstract][Full Text] [Related]
17. Effect of mepolizumab in severe eosinophilic asthma according to omalizumab eligibility.
Humbert M; Albers FC; Bratton DJ; Yancey SW; Liu MC; Hozawa S; Llanos JP; Kwon N
Respir Med; 2019; 154():69-75. PubMed ID: 31220806
[TBL] [Abstract][Full Text] [Related]
18. Tailored interventions based on sputum eosinophils versus clinical symptoms for asthma in children and adults.
Petsky HL; Li A; Chang AB
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD005603. PubMed ID: 28837221
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of mepolizumab in Japanese patients with severe eosinophilic asthma.
Shimoda T; Odajima H; Okamasa A; Kawase M; Komatsubara M; Mayer B; Yancey S; Ortega H
Allergol Int; 2017 Jul; 66(3):445-451. PubMed ID: 28110896
[TBL] [Abstract][Full Text] [Related]
20. Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease.
Poole P; Chong J; Cates CJ
Cochrane Database Syst Rev; 2015 Jul; (7):CD001287. PubMed ID: 26222376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
